The new trade policies, UBS said, are raising the cost of making a vehicle, subsequently raising the cost of a vehicle for consumers and negatively impacting demand.
The company said the plan aims to reduce the likelihood of any entity or person gaining control of Keros through open-market accumulation without paying all stockholders an appropriate control premium.
Ives estimates conservatively that 10%-15% of many cloud and AI initiatives in the U.S. he is tracking in the field could be pushed/slowed down during this period of uncertainty.
Several Wall Street analysts cut their price targets for Apple’s stock factoring in the negative impact of tariffs on the company’s top- and bottom-line.
Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes.
The airline reported a 3.3% rise in its adjusted revenue of $12.98 billion compared to an estimate of $13.46 billion, according to FinChat data. Adjusted earnings per share (EPS) stood at $0.46 versus a Street estimate of $0.39.
U.S. District Judge Edgardo Ramos in Manhattan said the plaintiffs failed to show that Bristol Myers and Celgene Corp violated the federal Sherman antitrust law.
While Morgan Stanley analyst Erik Woodring sees China confrontation risks unlocking the bear case for the stock, he remained positive due to “several mitigation efforts at play.”
The company expects quarterly adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) to exceed $22.5 million once final numbers are reported, exceeding expectations of $14.78 million.
RBC Capital opined that Pacira's settlement of litigation for generic Exparel, which provides some closure to over a year's worth of overhang and uncertainty for shares, is a win for the company and the Exparel franchise.
